Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer
ClinicalTrials.gov study NCT06792162. IPD Sharing: YES. Countries: 1. Publications: 0.
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast
ClinicalTrials.gov study NCT05422794. IPD Sharing: YES. Countries: 1. Publications: 0.
Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma
ClinicalTrials.gov study NCT03664323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise & Brain Energetics in PD
ClinicalTrials.gov study NCT04426786. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants
ClinicalTrials.gov study NCT02829541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes
ClinicalTrials.gov study NCT05792995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04101812. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors
ClinicalTrials.gov study NCT03851614. IPD Sharing: NO. Countries: 1. Publications: 0.
Short and Long-term Responses of PD Symptoms to Earstim
ClinicalTrials.gov study NCT07400731. IPD Sharing: NO. Countries: 1. Publications: 0.
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
ClinicalTrials.gov study NCT04966481. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC
ClinicalTrials.gov study NCT06360042. IPD Sharing: NO. Countries: 1. Publications: 0.
Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
ClinicalTrials.gov study NCT02080572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
ClinicalTrials.gov study NCT02581657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients
ClinicalTrials.gov study NCT02476019. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06550921. IPD Sharing: NO. Countries: 1. Publications: 0.
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)
ClinicalTrials.gov study NCT03002376. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016
ClinicalTrials.gov study NCT00740649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05843448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)
ClinicalTrials.gov study NCT05638815. IPD Sharing: NO. Countries: 1. Publications: 0.
Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC
ClinicalTrials.gov study NCT06657690. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.